Fundz Deep Dive

Everything you need to win Brett Kaplan — in one platform.

Who to reach, what to say, and why now on Brett Kaplan — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.

Get the full Deep Dive on Brett Kaplan — free.

One free Deep Dive, emailed to you. No spam; unsubscribe anytime.

Ready now? Choose your plan · Request a demo · Sign in

Engage writes the reply

Grounded in signals no one else has — tuned to their persona.

Signals no one else has

UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.

Verified contact + click-to-call

The decision-maker’s email and mobile — dial in-browser.

Eliem Therapeutics Appoints Brett Kaplan, M.D. As Chief Operating Officer and Nishi Rampal, M.D. As Senior Vice President, Clinical Development

PUBLIC · CLYMAug 26, 2024•almost 2 years ago

Position

Chief Operating Officer

Company

Eliem Therapeutics, Inc.

Brett Kaplan

BellevueBiotechnologyHealthcareHealth Careresearch

Description

Eliem Therapeutics, Inc. announced the appointments of Brett Kaplan, M.D., as Chief Operating Officer, and Nishi Rampal, M.D., as Senior Vice President, Clinical Development

Company Information

Company

Eliem Therapeutics, Inc.

Location

PMB #117, 2801 CENTERVILLE ROAD 1ST FL

Bellevue, Washington, United States

About

Eliem Therapeutics is a biotechnology company delivering therapies that empower patients to live on their own terms. Locations in US, with R&D operations in Cambridge, UK, Eliem channels its experience, energy, and passion for improving patients’ quality of life by developing and commercializing potentially “best-in-class” drug candidates to treat neuronal excitability disorders. These conditions—such as chronic pain, depression, epilepsy, and anxiety—cause deep suffering for tens of millions of people each day. At its core, the Eliem team is motivated by the promise of helping patients live happier, more fulfilling lives.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence

Strategic

ML-powered predictions for Eliem Therapeutics, Inc.'s next move

Learn about Strategic plan

Executive Insights

Based on hiring data

New executive impact window

87% of new executives make significant technology decisions within first 100 days

Budget influence

C-level executives control 73% of technology spending decisions

Transformation catalyst

65% of new senior hires launch digital transformation initiatives

Vendor review timeline

New executives typically review existing vendors within 6 months